UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Chronos Wealth Management LLC

Chronos Wealth Management LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,447 shares of the healthcare conglomerate’s stock after selling 90 shares during the quarter. UnitedHealth Group comprises approximately 4.9% of Chronos Wealth Management LLC’s holdings, making the stock its 9th largest position. Chronos Wealth Management LLC’s holdings in UnitedHealth Group were worth $9,138,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of UNH. Long Run Wealth Advisors LLC acquired a new stake in UnitedHealth Group during the first quarter valued at approximately $216,000. Wealth Alliance Advisory Group LLC lifted its position in shares of UnitedHealth Group by 1.5% during the 1st quarter. Wealth Alliance Advisory Group LLC now owns 4,731 shares of the healthcare conglomerate’s stock valued at $2,478,000 after acquiring an additional 70 shares during the last quarter. Nixon Peabody Trust Co. grew its holdings in shares of UnitedHealth Group by 34.0% in the 1st quarter. Nixon Peabody Trust Co. now owns 536 shares of the healthcare conglomerate’s stock worth $281,000 after acquiring an additional 136 shares during the last quarter. Financial Management Professionals Inc. lifted its holdings in shares of UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock valued at $1,165,000 after purchasing an additional 17 shares during the last quarter. Finally, Sendero Wealth Management LLC increased its stake in UnitedHealth Group by 23.0% in the 1st quarter. Sendero Wealth Management LLC now owns 3,540 shares of the healthcare conglomerate’s stock worth $1,854,000 after purchasing an additional 663 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

UNH has been the subject of several recent analyst reports. Wolfe Research decreased their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a report on Tuesday, May 20th. Hsbc Global Res cut shares of UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, May 21st. JPMorgan Chase & Co. reduced their target price on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating for the company in a report on Thursday, May 15th. Morgan Stanley dropped their price target on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 14th. Finally, HSBC reaffirmed a “reduce” rating and set a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. One analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $428.43.

UnitedHealth Group Stock Performance

UNH opened at $301.43 on Wednesday. The stock has a 50-day moving average of $422.31 and a 200-day moving average of $489.42. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a market cap of $273.44 billion, a PE ratio of 19.45, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the business earned $6.91 EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Activity

In related news, Director John H. Noseworthy acquired 300 shares of the business’s stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the completion of the transaction, the director now owns 6,063 shares of the company’s stock, valued at approximately $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO John F. Rex bought 17,175 shares of the firm’s stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the transaction, the chief financial officer now owns 203,796 shares of the company’s stock, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have acquired 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.